Latest Accretion Pharmaceuticals stock price
Accretion Pharmaceuticals P/E Ratio
ACCPL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
11.62
Low Valuation
Low - May indicate good value opportunity
Current Valuation Metrics
P/E Ratio
11.62
Current Price
₹
EPS (TTM)
₹8.48
Exchange
None
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
48.35
Sector Median
27.37
Sector Rank
#11 of 139
Sector Percentile
7.9%
Key P/E Ratio Insights for Accretion Pharmaceuticals
- Stock appears undervalued with PE of 11.62, suggesting potential buying opportunity
- Trading at discount to sector average PE of 48.35
View the ACCPL equity price for detailed stock performance.
Related Pages for Accretion Pharmaceuticals
Additional stock information and data for ACCPL
Sector P/E Ratio Comparison
Comparing Accretion Pharmaceuticals with other companies in Healthcare sector
Sector Average
48.35
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |